======= EZH1 ======= == Gene Information == * **Official Symbol**: EZH1 * **Official Name**: enhancer of zeste 1 polycomb repressive complex 2 subunit * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2145|2145]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92800|Q92800]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EZH1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EZH1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601674|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |EZH2 WD-Binding| |SET| |establishment of chromatin silencing| |nucleosomal histone binding| |chromatin silencing at telomere| |histone H3-K27 methylation| |ESC/E(Z) complex| |histone-lysine N-methyltransferase activity| |chromosome, telomeric region| |chromatin organization involved in negative regulation of transcription| |chromatin silencing| |chromatin organization involved in regulation of transcription| |histone lysine methylation| |negative regulation of gene expression, epigenetic| |hippocampus development| |peptidyl-lysine methylation| |histone methylation| |limbic system development| |protein alkylation| |protein methylation| |gene silencing| |chromatin remodeling| |pallium development| |regulation of gene expression, epigenetic| |transcription corepressor activity| |macromolecule methylation| |telencephalon development| |methylation| |peptidyl-lysine modification| |histone modification| |covalent chromatin modification| |forebrain development| |chromatin binding| |chromatin organization| |brain development| |head development| |negative regulation of transcription by RNA polymerase II| |peptidyl-amino acid modification| |central nervous system development| |chromosome organization| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp182|IU1-47 25μM R04 exp182]]|-1.79| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|1.73| |[[:results:exp442|Ibrutinib 10μM R08 exp442]]|1.86| |[[:results:exp77|Prochlorperazine 5.2μM R02 exp77]]|1.97| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12586 * **Expression level (log2 read counts)**: 5.79 {{:chemogenomics:nalm6 dist.png?nolink |}}